Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02803957Not ApplicableActive Not Recruiting

Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair

Role: lead

NCT05425628Not ApplicableUnknown

European FIH Study - NeoChord Transcatheter Mitral Repair System for Symptomatic Mitral Regurgitation

Role: lead

NCT04190602Recruiting

Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System

Role: lead

NCT01784055Completed

NeoChord TACT Post-Market Surveillance Registry

Role: lead

NCT01777815Not ApplicableCompleted

Safety and Performance Study of the NeoChord Device

Role: lead

All 5 trials loaded